Open access
Open access
Powered by Google Translator Translator

Oncology

Randomized trial: Colorectal cancer screening with repeated fecal immunochemical tests detects more colorectal cancer and advanced adenomas compared to screening sigmoidoscopy

25 Nov, 2020 | 09:05h | UTC

Colorectal cancer screening with repeated fecal immunochemical test versus sigmoidoscopy: baseline results from a randomized trial – Gastroenterology (link to abstract – $ for full-text)

 


Systematic review: Interventions for breathlessness in patients with advanced cancer

23 Nov, 2020 | 09:43h | UTC

Interventions for Breathlessness in Patients With Advanced Cancer – Agency for Healthcare Research and Quality

Full report: Interventions for breathlessness in patients with advanced cancer

Evidence Summary: Interventions for breathlessness in patients with advanced cancer

 


Treatment of community-acquired pneumonia in immunocompromised adults: A consensus statement regarding initial strategies

17 Nov, 2020 | 09:40h | UTC

Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies – CHEST

Editorial: Management of Community-Acquired Pneumonia in Immunocompromised Adults – CHEST

 


Guideline synopsis for follow-up colonoscopy after polypectomy. Repeat Col in 7 to 10 y after 1 to 2 tubular adenomas (TA) < 10 mm; Repeat Col in 3 to 5 y after 3 to 4 TA < 10 mm; Repeat Col in 3 y after 5 to 10 TA < 10 mm; Repeat Col in 3 years after 1 or more TA > 10 mm

9 Nov, 2020 | 01:17h | UTC

Recommendations for Follow-up Colonoscopy After Polypectomy – JAMA (free for a limited period)

Author interview: New Recommendations for How Often to Repeat Colonoscopy Following Polypectomy

Original guideline: Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer – Gastroenterology

 


Meta-analysis: Increased mortality due to cancer treatment delay

5 Nov, 2020 | 09:03h | UTC

Mortality due to cancer treatment delay: systematic review and meta-analysis – The BMJ

Editorial: Prioritising research into cancer treatment delays – The BMJ

 

Commentary on Twitter

 


[Abstract Only] Randomized, open-label trial: Olanzapine seems effective for the prevention of vomiting in children and adolescents receiving highly emetogenic chemotherapy

5 Nov, 2020 | 08:48h | UTC

Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator-Initiated, Randomized, Open-Label Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Study provides new estimates of breast cancer risks associated with different hormone replacement therapy preparations

30 Oct, 2020 | 01:04h | UTC

Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases – The BMJ

Commentaries: Study provides new estimates of breast cancer risks associated with HRT – University of Oxford AND New estimates of breast cancer risks associated with HRT – The BMJ AND HRT: Breast Ca Risk Tied to Hormone Type, Duration of Tx – Physician’s Weekly

 


KDIGO Controversies Conference on onco-nephrology

30 Oct, 2020 | 01:03h | UTC

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer – Kidney International

 

Commentary on Twitter

 


Randomized trial: Osimertinib in resected EGFR-Mutated non–small-cell lung cancer

29 Oct, 2020 | 09:04h | UTC

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer – New England Journal of Medicine

 


A systematic review of rehabilitation and exercise recommendations in oncology guidelines

29 Oct, 2020 | 09:02h | UTC

A systematic review of rehabilitation and exercise recommendations in oncology guidelines – CA: A Cancer Journal for Clinicians

 

Commentary on Twitter

 


USPSTF draft statement now recommends starting colorectal cancer screening at 45

28 Oct, 2020 | 08:57h | UTC

Draft Recommendation Statement: Colorectal Cancer Screening – U.S. Preventive Services Task Force

Commentaries: Colorectal cancer screening should start five years earlier — at 45 — expert panel says – STAT AND USPSTF Lowers Colorectal Cancer Screening Age to 45 in Draft Recommendation – NEJM Journal Watch

 


Clinical review: New advances in the diagnosis and management of hepatocellular carcinoma

28 Oct, 2020 | 08:47h | UTC

New advances in the diagnosis and management of hepatocellular carcinoma – The BMJ (free for a limited period)

 

Commentary on Twitter

 


Radiation therapy for rectal cancer: Executive summary of an ASTRO clinical practice guideline

28 Oct, 2020 | 08:45h | UTC

Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline – Practical Radiation Oncology

Commentaries: ASTRO issues clinical guideline on radiation therapy for rectal cancer AND ASTRO Issues Guideline on Radiation Therapy for Rectal Cancer – Physician’s Weekly

 

Commentary on Twitter

 


ASCO Guideline Update: Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer

27 Oct, 2020 | 09:32h | UTC

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update – Journal of Clinical Oncology

 


Meta-analysis: Evaluating prophylactic heparin in ambulatory patients with solid tumors

22 Oct, 2020 | 09:23h | UTC

Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis – The Lancet Haematology (free registration required)

 


COVID-19 and cancer: Current challenges and perspectives

14 Oct, 2020 | 09:35h | UTC

COVID-19 and Cancer: Current Challenges and Perspectives – Cancer Cell

Commentary: Study offers global review of impact of COVID-19 on cancer treatment and research – Dana-Farber Cancer Institute

 


Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study

12 Oct, 2020 | 00:31h | UTC

Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study – Intensive Care Medicine

 

Commentary on Twitter

 


Delivering cancer care during the covid-19 pandemic: recommendations and lessons learned from ASCO global webinars

2 Oct, 2020 | 09:19h | UTC

Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars – JCO Global Oncology

 


[Abstract Only] Atezolizumab for first-line treatment of PD-L1–selected patients with non–small-cell lung cancer

1 Oct, 2020 | 08:53h | UTC

Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC – New England Journal of Medicine

Commentary: Atezolizumab Leads to Longer OS for Some Types of Advanced NSCLC, Study Says – AJMC

 


[Abstract Only] Meta-analysis: Adjuvant vs. early salvage radiotherapy for the treatment of localized and locally advanced prostate cancer

29 Sep, 2020 | 10:04h | UTC

Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data – The Lancet

Commentaries: For Radiotherapy After Radical Prostatectomy, Salvage Therapy Should Be “Standard of Care” – NEJM Journal Watch AND Prostate cancer patients could be spared radiotherapy after surgery as new research suggests there is no benefit and it could be carried out later if the disease comes back – The Daily Mail

 


Randomized trials: Salvage radiotherapy vs. adjuvant radiotherapy after radical prostatectomy

29 Sep, 2020 | 10:03h | UTC

Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial – The Lancet

Related articles: Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial – The Lancet Oncology (free registration required) AND Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial – The Lancet Oncology (free registration required)

Commentaries: For Radiotherapy After Radical Prostatectomy, Salvage Therapy Should Be “Standard of Care” – NEJM Journal Watch AND Prostate cancer patients could be spared radiotherapy after surgery as new research suggests there is no benefit and it could be carried out later if the disease comes back – The Daily Mail

 


[Abstract Only] Meta-analysis: Direct oral anticoagulants for cancer-associated venous thromboembolism

28 Sep, 2020 | 01:22h | UTC

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis – Blood

 


Advanced Prostate Cancer: AUA/ASTRO/SUO Guidelines

24 Sep, 2020 | 09:15h | UTC

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I – The Journal of Urology

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II – The Journal of Urology

 


Clinical review: Emerging immunotherapies in multiple myeloma

23 Sep, 2020 | 14:33h | UTC

Emerging immunotherapies in multiple myeloma – The BMJ

 

Commentary on Twitter

 


[ESMO2020 press release – Not published yet] Randomized trial: No benefit for post-operative radiotherapy in non-small-cell lung cancer

22 Sep, 2020 | 09:23h | UTC

No benefit for post-operative radiotherapy in non-small-cell lung cancer – European Society of Medical Oncology

Commentary: Phase 3 Trial Results Do Not Support PORT in Resected Stage IIIAN2 NSCLC – Targeted Oncology

 


Stay Updated in Your Specialty

 

No spam, just news.